PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+28.63%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$896M
AUM Growth
–
Cap. Flow
+$896M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
71.41%
Holding
87
New
80
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$226M |
| 2 |
Sarepta Therapeutics
SRPT
|
$104M |
| 3 |
Neurocrine Biosciences
NBIX
|
$68M |
| 4 |
Biogen
BIIB
|
$49.8M |
| 5 |
Talphera
TLPH
|
$46.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 88.47% |
| 2 | Financials | 0.8% |
| 3 | Real Estate | 0.11% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGR
1
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $226M | 22.82% | +3,573,426 | New | +$226M |
|
|
2
Sarepta Therapeutics
SRPT
$1.78B
| $104M | 10.44% | +2,722,088 | New | +$104M |
|
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $68M | 6.86% | +5,081,717 | New | +$68M |
|
|
4
Biogen
BIIB
$19.4B
| $49.8M | 5.02% | +231,282 | New | +$49.8M |
|
|
5
Talphera
TLPH
$11.1M
| $46.4M | 4.68% | +5,008,400 | New | +$46.4M |
|
6
Gilead Sciences
GILD
$140B
| $40.4M | 4.08% | +788,360 | New | +$40.4M |
|
7
Regeneron Pharmaceuticals
REGN
$61.5B
| $31.3M | 3.16% | +139,310 | New | +$31.3M |
|
|
TSRO
8
DELISTED
TESARO, Inc.
TSRO
| $30.1M | 3.04% | +920,494 | New | +$30.1M |
|
9
Exact Sciences
EXAS
$8.98B
| $22.9M | 2.31% | +1,649,558 | New | +$22.9M |
|
10
Sonida Senior Living
SNDA
$488M
| $21.3M | 2.15% | +891,408 | New | +$21.3M |
|
11
Vertex Pharmaceuticals
VRTX
$100B
| $20.5M | 2.07% | +256,547 | New | +$20.5M |
|
|
NEPT
12
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $17.6M | 1.78% | +5,422,920 | New | +$17.6M |
|
|
STML
13
DELISTED
Stemline Therapeutics, Inc.
STML
| $14.1M | 1.42% | +591,650 | New | +$14.1M |
|
14
Madrigal Pharmaceuticals
MDGL
$9.76B
| $13.4M | 1.36% | +2,693,236 | New | +$13.4M |
|
15
Acadia Pharmaceuticals
ACAD
$4.38B
| $13.2M | 1.33% | +726,629 | New | +$13.2M |
|
|
SNTS
16
DELISTED
SANTARUS INC
SNTS
| $13.2M | 1.33% | +625,000 | New | +$13.2M |
|
|
CELG
17
DELISTED
Celgene Corp
CELG
| $11.3M | 1.14% | +96,256 | New | +$11.3M |
|
18
HCA Healthcare
HCA
$94.5B
| $11.1M | 1.12% | +308,560 | New | +$11.1M |
|
|
CHTP
19
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
| $10.7M | 1.08% | +4,658,680 | New | +$10.7M |
|
|
SLXP
20
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $9.81M | 0.99% | +148,250 | New | +$9.81M |
|
|
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
| $9.43M | 0.95% | +140,827 | New | +$9.43M |
|
|
NPSP
22
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $8.5M | 0.86% | +562,400 | New | +$8.5M |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $7.69M | 0.78% | +80,800 | New | +$7.69M |
|
|
AET
24
DELISTED
Aetna Inc
AET
| $7.17M | 0.72% | +112,825 | New | +$7.17M |
|
|
ELN
25
DELISTED
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
| $6.83M | 0.69% | +483,000 | New | +$6.83M |
|